These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 7993837)
1. Usefulness of indium-111 antimyosin scintigraphy in confirming myocardial injury in patients with anthracycline-associated left ventricular dysfunction. Valdés Olmos RA; ten Bokkel Huinink WW; ten Hoeve RF; van Tinteren H; Bruning PF; van Vlies B; Hoefnagel CA Ann Oncol; 1994 Sep; 5(7):617-22. PubMed ID: 7993837 [TBL] [Abstract][Full Text] [Related]
2. Myocyte cell damage after administration of doxorubicin or mitoxantrone in breast cancer patients assessed by indium 111 antimyosin monoclonal antibody studies. Estorch M; Carrió I; Martínez-Duncker D; Berná L; Torres G; Alonso C; Ojeda B J Clin Oncol; 1993 Jul; 11(7):1264-8. PubMed ID: 8315423 [TBL] [Abstract][Full Text] [Related]
3. High sensitivity of radiolabelled antimyosin scintigraphy in assessing anthracycline related early myocyte damage preceding cardiac dysfunction. Valdés Olmos RA; Carrió I; Hoefnagel CA; Estorch M; ten Bokkel Huinink WW; López-Pousa J; Dalesio O Nucl Med Commun; 2002 Sep; 23(9):871-7. PubMed ID: 12195092 [TBL] [Abstract][Full Text] [Related]
4. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies. Carrió I; Lopez-Pousa A; Estorch M; Duncker D; Berná L; Torres G; de Andrés L J Nucl Med; 1993 Sep; 34(9):1503-7. PubMed ID: 8355070 [TBL] [Abstract][Full Text] [Related]
5. Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. Estorch M; Carrió I; Berná L; Martínez-Duncker C; Alonso C; Germá JR; Ojeda B J Nucl Med; 1990 Dec; 31(12):1965-9. PubMed ID: 2266394 [TBL] [Abstract][Full Text] [Related]
7. Indium-111-antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children. Kremer LC; Tiel-van Buul MM; Ubbink MC; Offringa M; Ottenkamp J; Olmos RV; Voûte PA J Clin Oncol; 1999 Apr; 17(4):1208. PubMed ID: 10561180 [TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of radionuclide angiography and antimyosin immunoscintigraphy for risk assessment in epirubicin cardiotoxicity. Maini CL; Sciuto R; Ferraironi A; Vici P; Tofani A; Festa A; Conti F; Lopez M J Nucl Cardiol; 1997; 4(6):502-8. PubMed ID: 9456190 [TBL] [Abstract][Full Text] [Related]
9. Indium-111-antimyosin and iodine-123-MIBG studies in early assessment of doxorubicin cardiotoxicity. Carrió I; Estorch M; Berná L; López-Pousa J; Tabernero J; Torres G J Nucl Med; 1995 Nov; 36(11):2044-9. PubMed ID: 7472595 [TBL] [Abstract][Full Text] [Related]
10. Spectrum of alcohol-induced myocardial damage detected by indium-111-labeled monoclonal antimyosin antibodies. Ballester M; Martí V; Carrió I; Obrador D; Moya C; Pons-Lladó G; Bernà L; Lamich R; Aymat MR; Barbanoj M; Guardia J; Carreras F; Udina C; Augé JM; Marrugat J; Permanyer G; Caralps-Riera JM J Am Coll Cardiol; 1997 Jan; 29(1):160-7. PubMed ID: 8996309 [TBL] [Abstract][Full Text] [Related]
11. Myocardial damage assessed by indium-111-antimyosin: correlation with persistent enteroviral ribonucleic acid in dilated cardiomyopathy. Bengel FM; Feistel H; Moshage W; Bachmann K; Wolf F Eur J Nucl Med; 1997 Sep; 24(9):1128-31. PubMed ID: 9283105 [TBL] [Abstract][Full Text] [Related]
12. Antimyosin uptake and myofibrillarlysis in dilated cardiomyopathy. Narula J; Southern JF; Dec GW; Palacios IF; Newell JB; Fallon JT; Strauss HW; Khaw BA; Yasuda T J Nucl Cardiol; 1995; 2(6):470-7. PubMed ID: 9420828 [TBL] [Abstract][Full Text] [Related]
13. Myocardial indium-111 antimyosin uptake in patients with idiopathic dilated cardiomyopathy: its relation to haemodynamics, histomorphometry, myocardial enteroviral infection, and clinical course. Werner GS; Figulla HR; Munz DL; Klingel K; Kandolf R; Emrich D; Kreuzer H Eur Heart J; 1993 Feb; 14(2):175-84. PubMed ID: 8449193 [TBL] [Abstract][Full Text] [Related]
14. Assessment of anthracycline-induced myocardial damage by quantitative indium 111 myosin-specific monoclonal antibody studies. Carrió I; Estorch M; Berná L; Germá JR; Alonso C; Ojeda B; de Andrés L; Lopez-Pousa A; Martinez-Duncker C; Torres G Eur J Nucl Med; 1991; 18(10):806-12. PubMed ID: 1743203 [TBL] [Abstract][Full Text] [Related]
15. Myocardial uptake of 111In monoclonal antimyosin Fab in detecting doxorubicin cardiotoxicity in rats. Morphological and hemodynamic findings. Hiroe M; Ohta Y; Fujita N; Nagata M; Toyozaki T; Kusakabe K; Sekiguchi M; Marumo F Circulation; 1992 Dec; 86(6):1965-72. PubMed ID: 1451268 [TBL] [Abstract][Full Text] [Related]
18. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. Dec GW; Palacios I; Yasuda T; Fallon JT; Khaw BA; Strauss HW; Haber E J Am Coll Cardiol; 1990 Jul; 16(1):97-104. PubMed ID: 2358612 [TBL] [Abstract][Full Text] [Related]